Recent advances in the diagnosis of early stage lung cancer are showing promise to help improve treatment outcomes from this disease. In addition to CT scans, fluorescence bronchoscopy—a procedure approved by the FDA in 2005—is giving physicians the ability to diagnose lung cancer at its earliest, most treatable stages
